WAM
LIXTW

Warberg Asset Management’s Lixte Biotechnology Warrants LIXTW Stock Holding History

Warberg Asset Management’s Portfolio LIXTW Stock Details LIXTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-35,906
Closed -$1.6K – 213
2024
Q3 		$1.6K Sell
35,906
-1,968
-5% -$93 ﹤0.01% 194
2024
Q2 		$2.26K Sell
37,874
-3,001
-7% -$196 ﹤0.01% 204
2024
Q1 		$2.05K Hold
40,875
– – ﹤0.01% 194
2023
Q4 		$1.53K Hold
40,875
– – ﹤0.01% 209
2023
Q3 		$2.58K Sell
40,875
-12,306
-23% -$854 ﹤0.01% 217
2023
Q2 		$3.71K Hold
53,181
– – ﹤0.01% 207
2023
Q1 		$4.58K Buy
+53,181
New +$6.05K ﹤0.01% 220
2022
Q3 		– Sell
-12,000
Closed -$2K – 300
2022
Q2 		$2K Sell
12,000
-21,203
-64% -$4.28K ﹤0.01% 244
2022
Q1 		$8K Buy
33,203
+15,269
+85% +$3.91K ﹤0.01% 210
2021
Q4 		$8K Sell
17,934
-18,062
-50% -$7.09K ﹤0.01% 196
2021
Q3 		$20K Buy
35,996
+21,642
+151% +$14.2K ﹤0.01% 184
2021
Q2 		$11K Sell
14,354
-12,246
-46% -$8.73K ﹤0.01% 194
2021
Q1 		$22K Buy
26,600
+13,599
+105% +$13K 0.01% 145
2020
Q4 		$12K Buy
+13,001
New +$11.7K ﹤0.01% 148

Other funds holding LIXTW

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Warberg Asset Management's LIXTW Position: Q4 2024 in Review

Warberg Asset Management sold out of Lixte Biotechnology Warrants (LIXTW) in Q4 2024, closing a stake of 35,906 shares — an estimated $1.6K sold.

Warberg Asset Management first reported a position in LIXTW in Q4 2020 and held it in 14 quarters. The position peaked at $22K in Q1 2021. 2 funds tracked by Wall St. Rank hold LIXTW as of Q4 2024.

  • Warberg Asset Management reported no remaining Lixte Biotechnology Warrants position as of Q4 2024 after selling out during the quarter.
  • Warberg Asset Management sold 35,906 Lixte Biotechnology Warrants shares in Q4 2024, an estimated $1.6K.
  • Warberg Asset Management first reported a position in Lixte Biotechnology Warrants in Q4 2020 and held it in 14 quarters.
  • Warberg Asset Management's Lixte Biotechnology Warrants position peaked at $22K in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Lixte Biotechnology Warrants as of Q4 2024.

Based on Warberg Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.